InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
No posts yet, be the first!

Torii Pharmaceutical Co., Ltd (TRXPF) RSS Feed

Followers
0
Posters
0
Posts (Today)
0
Posts (Total)
0
Created
03/31/16
Type
Free
Moderators
Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products primarily in Japan. The company’s products include REMITCH agent for the treatment of pruritus in hemodialysis patients; Truvada and Stribild antiretroviral agent used for the treatment of HIV-1 infection in adults; ANTEBATE, an agent used for the treatment of the inflammatory manifestations of dermatosis; FUTHAN, an agent used for the prevention of blood coagulation during extracorporeal circulation and for the treatment of acute pancreatitis and disseminated intravascular coagulation; and Riona, an agent used for the enhancement of hyperphosphatemia in patients with chronic kidney disease; KAYEXALATE, an agent used for the enhancement of hyperkalemia caused by acute and chronic renal failure; and URINORM, an agent used for the treatment of hyperuricemia and gout. Its products for skin diseases and allergens comprise Dovonex, an agent used for the treatment of psoriasis vulgaris; ZEFNART, a topical antifungal agent used for the treatment of tinea, including tinea pedis; and LOCOID, an agent used to treat the inflammatory manifestations of dermatosis. Torii Pharmaceutical Co., Ltd. markets and sells its products through medical representatives in Japan. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
TRXPF Latest News
  • No Recent News Available for this company!
New Post